| Product Code: ETC12838601 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The import shipments of influenza medications to Brunei in 2024 were primarily sourced from Malaysia, Singapore, Ireland, the United States of America, and Australia. The market showed a significant increase in concentration, with the Herfindahl-Hirschman Index (HHI) reaching very high levels. Despite a negative Compound Annual Growth Rate (CAGR) over the period 2020-2024, the market experienced a slightly improved growth rate in 2024 compared to the previous year. This data suggests a stable but concentrated market for influenza medications in Brunei, with key suppliers continuing to dominate the import landscape.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Brunei Influenza Medications Market Overview |
3.1 Brunei Country Macro Economic Indicators |
3.2 Brunei Influenza Medications Market Revenues & Volume, 2022 & 2032F |
3.3 Brunei Influenza Medications Market - Industry Life Cycle |
3.4 Brunei Influenza Medications Market - Porter's Five Forces |
3.5 Brunei Influenza Medications Market Revenues & Volume Share, By Drug Type, 2022 & 2032F |
3.6 Brunei Influenza Medications Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.7 Brunei Influenza Medications Market Revenues & Volume Share, By Patient Age Group, 2022 & 2032F |
4 Brunei Influenza Medications Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of early influenza treatment |
4.2.2 Growing prevalence of influenza cases in Brunei |
4.2.3 Government initiatives to improve healthcare infrastructure and access to medications |
4.3 Market Restraints |
4.3.1 High cost of influenza medications |
4.3.2 Limited availability of advanced or specialized influenza treatments in Brunei |
5 Brunei Influenza Medications Market Trends |
6 Brunei Influenza Medications Market, By Types |
6.1 Brunei Influenza Medications Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Brunei Influenza Medications Market Revenues & Volume, By Drug Type, 2022 - 2032F |
6.1.3 Brunei Influenza Medications Market Revenues & Volume, By Antiviral Drugs (Oseltamivir, Zanamivir, Peramivir, Baloxavir), 2022 - 2032F |
6.1.4 Brunei Influenza Medications Market Revenues & Volume, By Symptom Relief Medications (Pain Relievers, Decongestants, Antihistamines), 2022 - 2032F |
6.2 Brunei Influenza Medications Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Brunei Influenza Medications Market Revenues & Volume, By Oral, 2022 - 2032F |
6.2.3 Brunei Influenza Medications Market Revenues & Volume, By Intravenous (IV), 2022 - 2032F |
6.2.4 Brunei Influenza Medications Market Revenues & Volume, By Inhalation, 2022 - 2032F |
6.3 Brunei Influenza Medications Market, By Patient Age Group |
6.3.1 Overview and Analysis |
6.3.2 Brunei Influenza Medications Market Revenues & Volume, By Pediatric, 2022 - 2032F |
6.3.3 Brunei Influenza Medications Market Revenues & Volume, By Adult, 2022 - 2032F |
6.3.4 Brunei Influenza Medications Market Revenues & Volume, By Geriatric, 2022 - 2032F |
7 Brunei Influenza Medications Market Import-Export Trade Statistics |
7.1 Brunei Influenza Medications Market Export to Major Countries |
7.2 Brunei Influenza Medications Market Imports from Major Countries |
8 Brunei Influenza Medications Market Key Performance Indicators |
8.1 Number of influenza cases reported annually in Brunei |
8.2 Percentage of population vaccinated against influenza |
8.3 Rate of adoption of new influenza medications in the market |
9 Brunei Influenza Medications Market - Opportunity Assessment |
9.1 Brunei Influenza Medications Market Opportunity Assessment, By Drug Type, 2022 & 2032F |
9.2 Brunei Influenza Medications Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.3 Brunei Influenza Medications Market Opportunity Assessment, By Patient Age Group, 2022 & 2032F |
10 Brunei Influenza Medications Market - Competitive Landscape |
10.1 Brunei Influenza Medications Market Revenue Share, By Companies, 2025 |
10.2 Brunei Influenza Medications Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here